(Q39010675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

main subject

Staphylococcus aureus

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Arnaud Hequet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Olga N Burchak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Matthieu Jeanty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Emmanuelle Le Pihive

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Laure Maigre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Pascale Bouhours

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Dominique Schneider

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Max Maurin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jean-Marc Paris

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jean-Noël Denis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Claude Jolivalt

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

26 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

1534-1545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24677763%20AND%20SRC:MED&resulttype=core&format=json

The clinical consequences of antimicrobial resistance

12 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Infections caused by Gram-positive bacteria: a review of the global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Serious infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

MRSA burden and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

The effect of antibiotics on methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Clinical approach to severe Clostridium difficile infection: update for the hospital practitioner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Clinical management of ESBL-producing Enterobacteriaceae: the insidious role of fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Small multidrug resistance proteins: a multidrug transporter family that continues to grow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Active export proteins mediating drug resistance in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Efflux-mediated antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

The global need for effective antibiotics-a summary of plenary presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Fighting bacterial infections-future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Bacterial efflux systems and efflux pumps inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Inhibitors of multidrug resistant efflux systems in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Bacterial efflux pump inhibitors from natural sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Antibacterial activity of indole alkaloids from Aspidosperma ramiflorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Total Synthesis of Marine Sponge Bis(indole) Alkaloids of the Topsentin Class

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Inducible NorA-mediated multidrug resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Mechanism of action of and resistance to quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021

“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021

Evolution from a Natural Flavones Nucleus to Obtain 2-(4-Propoxyphenyl)quinoline Derivatives As Potent Inhibitors of theS. aureusNorA Efflux Pump

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021

The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021

Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021

Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021

Total syntheses of brominated marine sponge alkaloids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021

2,2,2-trifluoroethyl formate: a versatile and selective reagent for the formylation of alcohols, amines, and N-hydroxylamines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400042

7 January 2021